Other
Vaccine
0
Pipeline Programs↗
42
Active Trials↗
35
Companies Involved↗
Vaccine is an early-stage landscape with 0 programs across 35 companies. The most active players are Sanofi, GSK, Pfizer.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
527
clinical trials
Completed410 · 78%
Unknown status40 · 8%
Terminated22 · 4%
Recruiting20 · 4%
Active, not recruiting16 · 3%
Withdrawn12 · 2%
Other7 · 1%
Clinical Trials
Trial Activity
527 trials
HER-2 B Cell Peptide Vaccine
Recruiting·—·Phase 1·NCT06414733·42 enrolled
Extended Dosing Intervals Trial for Oral Cholera Vaccine, Kenya
Recruiting·—·Phase 4·NCT07487077·1,071 enrolled
Comparability Trial of the MVA-BN Vaccine Manufactured in Different Production Cells
Recruiting·—·Phase 2·NCT07199569·744 enrolled
Page 1 of 36
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)